IP Library Assignment 048400/0612
Patent Assignment
Reel/Frame 048400/0612

Assignment of Assignor's Interest

Recorded: 2019-02-21 Pages: 3
Assignor
TARGANTA THERAPEUTICS CORP.
Executed: 2013-02-21
Assignee
THE MEDICINES COMPANY
8 SYLVAN WAY, PARSIPPANY, NEW JERSEY, 07054
Covered Property (1)
Methods of Treatment Using Single Doses of Oritavancin
Application: 13/763,799 →
Publication: US 2013/0172237
Related Assignments (6)
Other recorded transfers of the patent in this record — the chain of ownership.
Security Interest Jan 8, 2018
From: MELINTA THERAPEUTICS, INC.; REMPEX PHARMACEUTICALS, INC.; CEMPRA PHARMACEUTICALS, INC.; CEM-102 PHARMACEUTICALS, INC.
To: CORTLAND CAPITAL MARKET SERVICES LLC, AS AGENT
Reel/Frame 045019/0552 →
Assignment of Assignor's Interest Feb 21, 2019
From: LEHOUX, DARIO; PARR, THOMAS R.; MOECK, GREGORY; ETIENNE, PIERRE
To: TARGANTA THERAPEUTICS CORP.
Reel/Frame 048400/0572 →
Assignment of Assignor's Interest Feb 21, 2019
From: THE MEDICINES COMPANY
To: MELINTA THERAPEUTICS, INC.
Reel/Frame 048407/0911 →
Amended and Restated Intellectual Property Security Agreement Aug 25, 2022
From: TARGANTA THERAPEUTICS CORPORATION
To: SILICON VALLEY BANK
Reel/Frame 061314/0659 →
Termination and Release of Intellectual Property Security Agreement (Patents) at Reel 061314 and Frame 0659 Aug 29, 2025
From: SILICON VALLEY BANK, A DIVISION OF FIRST-CITIZENS BANK & TRUST COMPANY
To: TARGANTA THERAPEUTICS CORPORATION
Reel/Frame 073724/0550 →
Change of Name Sep 23, 2025
From: MELINTA THERAPEUTICS, INC
To: MELINTA THERAPEUTICS, LLC
Reel/Frame 072952/0173 →